# Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections

> **NCT02171338** · PHASE4 · UNKNOWN · sponsor: **Holbaek Sygehus** · enrollment: 55 (estimated)

## Conditions studied

- Pneumonia
- Acute Exacerbation of Chronic Obstructive Airways Disease

## Interventions

- **OTHER:** PCT-level
- **BEHAVIORAL:** Antibiotic treatment based on PCT-level

## Key facts

- **NCT ID:** NCT02171338
- **Lead sponsor:** Holbaek Sygehus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2014-08
- **Final completion:** 2014-09
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2014-08-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02171338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02171338, "Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02171338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*